2023
DOI: 10.3390/pharmaceutics15061747
|View full text |Cite
|
Sign up to set email alerts
|

Polymorphism of Carbamazepine Pharmaceutical Cocrystal: Structural Analysis and Solubility Performance

Artem O. Surov,
Ksenia V. Drozd,
Anna G. Ramazanova
et al.

Abstract: Polymorphism is a common phenomenon among single- and multicomponent molecular crystals that has a significant impact on the contemporary drug development process. A new polymorphic form of the drug carbamazepine (CBZ) cocrystal with methylparaben (MePRB) in a 1:1 molar ratio as well as the drug’s channel-like cocrystal containing highly disordered coformer molecules have been obtained and characterized in this work using various analytical methods, including thermal analysis, Raman spectroscopy, and single-cr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 83 publications
(117 reference statements)
0
4
0
Order By: Relevance
“…Beyond the fact that cocrystals are solid forms different from the solid reactants they originate, literature also lately reported several examples of polymorphic cocrystals and solvate cocrystals. These are mostly produced by conventional methods. Though the potentiality of scCO 2 -based techniques to control polymorphism has been addressed for homocrystals, only few articles reported polymorphism of cocrystals, , one for the production of a solvate, and none has ever reported the obtention of a cocrystal solvate.…”
Section: Introductionmentioning
confidence: 99%
“…Beyond the fact that cocrystals are solid forms different from the solid reactants they originate, literature also lately reported several examples of polymorphic cocrystals and solvate cocrystals. These are mostly produced by conventional methods. Though the potentiality of scCO 2 -based techniques to control polymorphism has been addressed for homocrystals, only few articles reported polymorphism of cocrystals, , one for the production of a solvate, and none has ever reported the obtention of a cocrystal solvate.…”
Section: Introductionmentioning
confidence: 99%
“…CBZ is an anticonvulsant drug that has been widely used in clinics for more than 50 years to treat epilepsy, trigeminal neuralgia, and bipolar disorder . CBZ is a commonly used API for cocrystallization with highly soluble coformers due to its low water solubility and irregular gastrointestinal absorption . To date, over 60 crystal structures of the CBZ multicomponent crystals, including cocrystals, salts, and their hydrates/solvates/polymorphs, have been deposited in the Cambridge Structural Database (CSD), and the number continues to expand annually. , Despite the variety of crystal structures, no ternary cocrystals of CBZ have been obtained.…”
Section: Introductionmentioning
confidence: 99%
“…CBZ is a commonly used API for cocrystallization with highly soluble coformers due to its low water solubility and irregular gastrointestinal absorption . To date, over 60 crystal structures of the CBZ multicomponent crystals, including cocrystals, salts, and their hydrates/solvates/polymorphs, have been deposited in the Cambridge Structural Database (CSD), and the number continues to expand annually. , Despite the variety of crystal structures, no ternary cocrystals of CBZ have been obtained. Meanwhile, such an attempt has already been made, resulting in a new polymorph of the CBZ binary cocrystal with 4-hydroxybenzoic acid …”
Section: Introductionmentioning
confidence: 99%
“…The number of medications based on active pharmaceutical ingredients (API) in the form of salts and complexes has increased in recent decades, both in the total number and in the number of cations used [ 1 , 2 , 3 ]. This growth is related to ability of cations to tune physical chemical properties of an API, such as solubility or tabletability [ 4 , 5 , 6 , 7 , 8 ], and increased selectivity of their supramolecular binding with biological macromolecules and/or bioactivity [ 9 , 10 ], as well as to the existence of metallopharmaceuticals [ 11 , 12 , 13 , 14 ], metallodrugs, and bioMOFs with controlled release of API [ 15 , 16 , 17 , 18 , 19 , 20 ]. The Orange Book of Approved Drug Products with Therapeutic Equivalence Evaluations [ 21 ] contains information about salts of sodium, potassium, calcium, magnesium, iron, platinum, silver, and zinc.…”
Section: Introductionmentioning
confidence: 99%